Clinical Trial Update: A Study to Assess the Concentrations of Risankizumab in the Breast Milk of Adult Lactating Women With Inflammatory Bowel Disease [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial completed to assess the concentrations of risankizumab in the breast milk of adult lactating women with inflammatory bowel disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Inflammatory Bowel Disease

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Inflammatory Bowel Disease | Phase 4 | Status: COMPLETED